Good afternoon, and welcome to the Superior Group of Companies' First Quarter 2025 Conference Call. With us today are Michael Benstock, Chief Executive Officer; and Mike Koempel, Chief Financial Officer. As a reminder, this conference is being recorded. This call may contain forward-looking statements regarding the company's plans, initiatives and strategies and the anticipated financial performance of the company, including, but not limited to, sales and profitability. Such statements are based upon management's current expectations, projections, estimates, and assumptions. Words such as expect, believe, anticipate, think, outlook, hope and variations of such words and similar expressions identify such forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties that may cause future results to differ materially from those suggested by forward-looking statements. Such risks and uncertainties are further disclosed in the company's periodic filings with the Securities and Exchange Commission, including the company's most recent Annual Report on Form 10-K and the quarterly reports on Form 10-Q. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and cautioned not to place undue reliance on such forward-looking statements. The company does not undertake to update the forward-looking statements, except as required by law. And now, I'll turn the call over to Michael Benstock.

Thank you, and welcome everyone to today's call. As usual, I'll start with a review of consolidated financial highlights for the first quarter, including a discussion around our three business segments and current market conditions. Mike will then walk us through our financial results in more detail. Then we'd be happy to take your questions. So let's get started. Our customer buying hesitancy persisted through the quarter. On top of the uncertainty around inflation and interest rates, the recently introduced tariffs that have already been revised a few times, in particular, the ever-escalating China tariff rate, not only further slowed customer decision making but has made sourcing of our products somewhat of a challenge. The good news is that SGC has successfully navigated numerous economic challenges in the past, and we entered 2025 in a strong financial position to manage through the current economic uncertainty. Of course, we have no line of sight to what the next move by our executive branch will be and what counter moves will take place in this tit-for-tat environment. As many of you are aware, for decades, we have had a redundant manufacturing and sourcing strategy in place for most of what we produce. This competitive strategy has helped us greatly in the past, no matter the challenging environment. Let me point out for those of you who are new to our story that we are not heavily invested in China manufacturing or sourcing our finished products for our Healthcare segment or, of course, for our call center segment. But a handful of our customers' products that we support in our call centers will be impacted by high tariffs on China-made products brought into the USA, which could ultimately impact their businesses and create a trickle-down effect to us. It is also true that some of our customers could competitively benefit from high tariffs on products from China or elsewhere. During these challenging times, we have the advantage of leveraging the diversification of our three business segments combined with our multiple sources of supply. We remain focused on what we can control, which you can well imagine is centered on strong cost management. The costs we've recently eliminated from the business that Mike will speak to will support even stronger profitability as demand normalizes. Taking a look at our consolidated first-quarter results, we held revenue nearly flat year-over-year despite the macro headwinds and lapping a 6% increase in the first quarter a year ago. Growth in our contact center business was offset by a slight decline in Branded Products, our largest segment, and a decline in Healthcare Apparel. Also on a consolidated basis, we recorded a first quarter net loss per share of $0.05 relative to earnings per diluted share of $0.24 in the prior year period. The profit decline was primarily the result of lower gross margins from sales mix changes that included fewer orders from higher margin customers. Despite the quarterly net loss, we maintained a strong balance sheet and net leverage position, which allows us to take a strategic long-term approach to capital allocation. This includes prudently investing in our three attractive businesses while capitalizing on market dislocations to actively repurchase our common shares, which we consider a compelling value. Turning to our business segments and starting with Branded Products. Sales of promotional products grew while branded uniform sales with existing customers were down year-over-year, primarily due to stronger uniform program rollouts in the year-ago quarter. Overall, our pipeline of business opportunities in branded products is setting new records. Our order backlog remains strong, and our customer retention continues to be over 90%. This gives us line of sight to Q2 being a relatively strong quarter. In addition, we continue to recruit new sales reps, win new accounts, and expand wallet share with our existing base. All these actions will enable us, as we have in every crisis, to gain overall market share as we still control only a very small portion of this attractive market as the eighth largest of more than 25,000 distributors. Turning to Healthcare Apparel. Economic uncertainty is also having an impact, most notably in institutional Healthcare Apparel and in our brick-and-mortar wholesale-related channel. We are investing and we'll continue to invest in growing our digital channels, both wholesale and direct-to-consumer, to continue expanding our single-digit market share in this growth industry. We're also spending to drive demand creation for our Wink and our Carhartt licensed brand products, albeit being very strategic while doing so. As for contact centers, while not immune to current macro uncertainty in end markets, this remains our highest margin segment. We have begun to realize the benefits of our first-ever sales team through successfully participating and winning RFPs as well as developing a record pipeline. We will continue to test and utilize cutting-edge technology that enhances the customer experience, enables operational efficiency, and serves as a competitive advantage, particularly as we target high-touch small- and medium-sized enterprises. With that, I'll turn the call over to Mike, who will take us through first-quarter results in detail, and then we'll open it up for Q&A.

Thank you, Michael, and again, welcome to our call. On a year-over-year basis, our consolidated first-quarter revenues were down 1%. Taking this segment by segment, for branded Products, revenue was off less than 1%, an improvement over the fourth quarter's 5% decline. Consistent with last quarter, sales of promotional products grew, while branded uniform sales with existing customers were down year-over-year, primarily due to stronger uniform program rollouts in the year-ago quarter as well as hiring freezes implemented by some of our customers during the first quarter. For Healthcare Apparel, first quarter revenue was down 7% versus the prior year, reflecting a decline in institutional Healthcare Apparel. For our contact center business segment, we were able to grow revenue 3% with solid retention and growth of existing customers as well as adding new customers benefiting from our internal sales force. Moving on to gross margin. On a consolidated basis, the gross margin rate was 36.8% for the first quarter, nearly flat sequentially and compared to 39.8% in the prior year. SG&A was 36.5% of revenues compared to 35.2% in the prior year quarter, and consolidated EBITDA came in at $3.5 million versus $9.6 million a year earlier. Let's take a closer look by segment. Our Branded Products gross margin was 32% in the first quarter, which compares to 36.5% a year earlier, primarily the result of sourcing mix that led to higher product costs as well as customer mix that led to lower pricing. SG&A for Branded Products was up just slightly at 27.1% of revenues, and we generated EBITDA of $5.7 million compared to $9.9 million in the prior year quarter. Moving on to Healthcare Apparel. Our first-quarter gross margin of 37.2% was up sequentially but compares to 39.4% in the prior year period, with both variances reflecting changes in underlying cost of goods. In terms of SG&A for Healthcare Apparel, it was 34.9% of sales, up from 33.6% a year earlier, reflecting expense deleverage on this quarter's sales. The result was $1.5 million in Healthcare Apparel EBITDA as compared to $2.6 million in the first quarter of 2024. Lastly, on contact centers, we held gross margin essentially flat year-over-year at 53.6%, and SG&A as a percentage of revenues was 45.1%, up 90 basis points due to an increase in professional fees. The resulting EBITDA of $2.8 million was just slightly below $2.9 million in the year-ago quarter. Moving further down the income statement, interest expense net was $1.2 million during the first quarter, improved from $1.8 million in the year-ago quarter due to a lower weighted average interest rate. The net loss for the quarter was approximately $800,000 compared to net income of $3.9 million in the first quarter of 2024, resulting in a net loss per share of $0.05 as compared to earnings per diluted share of $0.24 last year. Turning to the balance sheet. We ended the first quarter with $20 million in cash and cash equivalents, up from $19 million to start the year. We have also been actively repurchasing shares under the Board's authorization that was recently expanded, as mentioned on our last call. We consider the repurchases to be a favorable use of cash and completed $3.8 million worth of share buyback during the first quarter to repurchase approximately 294,000 shares. Overall, we ended March with a net leverage ratio of 2.2x trailing 12-month covenant EBITDA versus 1.7x to start the year. We had anticipated a first-quarter increase in net leverage given the back-end weighted nature of our forecast at the beginning of the year and the timing of cash outflows. We remain well within our covenant requirements and continue to maintain significant liquidity to support the growth of our business. Turning to our updated full-year outlook. Given the heightened economic uncertainty following the April tariff announcements, we currently expect revenues to be in the range of $550 million to $575 million, suggesting year-over-year growth at the high end of about 2%. This compares to our prior outlook range of $585 million to $595 million. Clearly, the economic uncertainty is resulting in macro volatility that has many companies, including our clients, delaying decision-making. Therefore, due to the bottom line sensitivity to tariffs and other developments as we move through the year, we are not providing an earnings per share outlook at this time. It is important to reiterate that we have a proven track record of successfully navigating challenging economic times. The significant improvement that we have driven over the last 2 years in operating cash flow, working capital and net leverage places our company in a position of strength relative to many of our competitors. So while we are managing our cash flow and expenses tightly during these uncertain times, including a reduction of approximately $13 million in annualized budgeted expenses, which will begin to impact the second quarter, we also remain laser-focused on driving growth and leveraging our position of strength to gain market share. With that, operator, Michael and I would be happy to take questions if you could please open the lines.

Thanks. Good afternoon. I wanted to just start off by talking about the pipeline. You mentioned some really strong pipelines in both branded products and contact centers, despite the uncertain environment that you're operating in. So maybe just talk about what's going well for you there. It sounds like you're being very aggressive in Branded Products, as you always are, and you can take advantage of some opportunities in this environment. So maybe just love to hear more color on your ability to build the pipeline in those businesses.

Thank you, Kevin. That's a great question. Let's begin with Branded Products. The team has effectively responded to the challenges posed by tariffs by actively recruiting and conducting webinars aimed at helping customers navigate these issues. They've established themselves as experts, particularly with their close ties to the on-ground situation in China. Additionally, due to a resilient manufacturing and sourcing strategy we've developed over the years, much of our production has shifted to other countries since the early Trump administration. While some categories, such as electronics and certain stainless steel drinkware, still rely heavily on China, customers do have alternatives. They can opt for apparel and other soft goods, and we've adequately positioned ourselves to take advantage of that shift. I encourage everyone on the call to visit BAMKO's website, where we have three webinars available discussing strategies to mitigate tariff impacts. We've had considerable interest from prospects, and we've even opened these sessions to competitors and suppliers, further establishing our expertise and driving additional business our way. As a company, we have a history of turning challenges into opportunities, and during COVID, we made significant adjustments. We continue to make pivoting efforts, and BAMKO is in a strong position with solid bookings and a growing pipeline. While some opportunities are taking longer to close, the pipeline is expanding due to new chances that have emerged, leading to unexpected positive developments even in recent weeks. This overall situation gives us confidence for Q2, as we have a clear perspective on its trajectory. However, we're uncertain about Q3. While we anticipate a strong start, the latter part of Q3 and Q4 remains unpredictable. Typically, our performance leans towards the end of the year, and if that pattern holds, we should emerge from this phase stronger than many competitors. Moving on to the contact centers, we have successfully built our sales team, leading to increased opportunities. Although we expect some fluctuations from our customers over time, particularly later this year if current trends persist, we are also onboarding new customers at a faster rate than before. Therefore, we are optimistic about our prospects. Unfortunately, the specific actions from Washington remain uncertain. We hope for a gradual easing of the current stance rather than a tightening one, and most of our forecasts take this into consideration.

All right. That's very helpful color. I appreciate it. And so with the reduced revenue guidance, like you said, you feel good about the second quarter. So are you just trying to build some conservatism into the second half, I guess, given the more limited visibility around that traditional ramp-up in the second half?

I believe we'll still have a ramp-up in the second half. But yes, of course, we're building conservatism on the current environment of not knowing who's going to say what next. We're just trying to be extremely cautious. And we're managing our costs within the business on an extremely conservative basis also.

Okay. I guess, lastly, can you just discuss just from a cost perspective, again, maybe a review as things stand now anyway, your exposure from a cost perspective to tariffs and your ability to pass on through price increases if needed?

It's by business, you've got to look at it. So we'll pass on increases that we incur to most of our customers. We're permitted to do so, either by contract or on a PO-by-PO basis. We're going to try to recoup as much of the tariff as possible through price increases. And we believe that we'll have that well under control. But obviously, there may be some timing issues. We're not always allowed every moment to raise, sometimes by contract on a certain date or within a certain amount of notice, you have to keep in mind that we're a replenishment business. And we already have containers coming in that are subject to the higher tariffs. So we've got to be ever aware of that. And I think our customers are certainly hearing that from their other vendors. So it's not as if it's a surprise to them. Now, when you get to Healthcare Apparel, that's the branded products outlook. When you get to Healthcare Apparel, it's the same. If tariffs exist, we've got to pass them on. In the direct-to-consumer business, we just raise our prices directly to consumers. If it's direct through the wholesale channels, we will raise our prices. If on the institutional side of the business, which is particularly slow right now because they're more in a wait-and-see mode and there's no compelling reason for them to have to move forward quickly. They'll take a much slower approach to this. They'll wait and flesh out and see what happens with the tariffs before they start buying again. They have been impacted somewhat by the institutional side, which has been affected by some of the pullbacks by the government on funding of research and so on. But our main products, scrubs in particular, are not generally impacted that much by research, but they are to some extent. It's more lab coats and different other types of protective gear that are affected by that. The contact centers, where we have increases, is going to be in only a few places really. And it's more how our customers are impacted by increases they have on the products that we're supporting in the call center. But I feel like we'll come out of this okay. And of course, our guidance with respect to the top line is how many things can't we replace? When you look at pulling our guidance down that far, it really has to do with the items within branded products that can't be sourced elsewhere, which I spoke about earlier, such as electronics and some of the injection molded plastic items and the double-wall drinkware. But again, we're taking a conservative approach to this. It could very well be we're able to take all those customers who want those items and get them into other items in other countries that will be less impacted.

Okay. Thank you. I appreciate all the insight. I will turn it back over.

Hi, good afternoon. Thanks for taking the questions. So it seems like customers react pretty quickly when the tariffs are announced. Should deals be made with other countries, including China, how fast do you think customers would react the other way?

It's an interesting question. I think one of the issues that the entire country is faced with, Jim, is that the analysis we've seen on even if tomorrow Washington said, 'Hi, we're kidding,' it would take 6 to 9 months from today before we'd see things getting closely back to normal because the supply chain has been so disrupted. Factories in a lot of places have let their workers go. They've run their lines out. They let them go. They're not taking on any new business. They got to bring them all back. It's kind of like after the Chinese New Year, where it takes a month to get everybody back to work and then ramp back up takes another month. And then logistically, container ships are all in the wrong places. They're not sitting in China right now. They're elsewhere. So they got to reposition them. They got to get all the containers that were called Independence Day sent to the U.S., and that ties up a lot of containers with not enough ships to carry them. So we've seen some analysis from pretty smart people that say we could be in for some supply chain disruption, not just in our business, in every business that's manufacturing outside the United States and more offshore than nearshore for the next year, year and a half.

Right. And you mentioned that you think you can implement about $13 million in cost savings on an annualized basis. Where do you get that? What lines do you think that impacts?

Hi, Jim, it's Mike. So all these cuts would be within our SG&A expense line, and it's really looking across all of our segments and a number of different types of expenses where we just find opportunities for us to become more efficient and leaner. So we're very comfortable that the cuts that we've taken will not impact our ability to continue to grow the business or again, as things become more clear and we hopefully get on the other end of these high tariffs, we'll still be in a position to still grow and drive the business. So again, I think largely operational efficiencies across all three of our segments.

Keep in mind, Jim, I'll jump in, that we were staffed to support a $585 million to $595 million business. As we realize that it will be a number less than that, we reduced accordingly. And that's really the gist of it.

Okay. And then the last one for me. I know you don't want to get too detailed on guidance, but for the quarter that just ended, you had a gross margin around 37%. Is that a good proxy for the rest of the year?

Jim, I would say, if you look at the first quarter, clearly, the Branded Products margin rate was down from last year and down versus the trend, as I'm sure you know. We would expect under, I'll say, normal circumstances for that margin to rebound as we move throughout the year. Again, putting aside what we're talking about in terms of potential impacts as it relates to China and tariffs and whatnot, under normal circumstances, we would expect that to rebound. In the first quarter, we had some sourcing cost mix, some pricing mix with some larger orders year-over-year. That created a decrease in the first quarter, and we wouldn't anticipate that in the second quarter.

Hi, guys. Thank you very much for taking the question. First I wanted to ask, just looking at the cash flow statement here and seeing you guys had a pretty big reduction in AP and current liabilities. Is that just a seasonal impact, Mike, just kind of a typical seasonal trend there?

It is more of a seasonal impact in the first quarter. We typically have larger payments associated with bonus payments for the prior year payments that we make with some of our benefit plans. So those again, tend to be more weighted in the first quarter, which you can see really in both years, we had both first quarters and we had significant declines in those accounts year-over-year.

Got you. So as that washes out over the course of the year, that will be less of a drag on cash flow and allow you to generate a little bit more operating cash flow throughout the course of the year, right?

Sure. That would be our expectation.

Right. Okay. And then just kind of turning to the P&L side. I guess you were able to hold SG&A pretty steady year-over-year really. Could you give us a little bit more insight on where you think you might be able to realize some savings there? Just to help us understand kind of timing and how that would flow through?

Sure. Well, as we mentioned in the prepared remarks, we executed approximately $13 million in annualized savings. We put those measures in place in the April time frame. So we'll begin to see the benefit of those cuts starting here in the second quarter. There are certain reductions, whether it's contractual or just periods where we need to transition where some of those savings will materialize a little bit later in the year, but the vast majority will start to benefit in the second quarter and again, hold throughout the balance of the year.

Okay. And then just lastly for me. As things get a little bit choppier in the water here, you guys did actually do a small acquisition last quarter, I believe it was, and you're pretty well positioned from a liquidity perspective to perhaps capitalize on some opportunities should they come up. Are you starting to see anything where there are opportunities to make some acquisitions? And what space would you really focus on first and foremost as you evaluate those opportunities?

First and foremost, right now, we're conserving cash. We don't know what the future is going to bring. So we have put while we're still talking to potential companies about joining us, we would not right now entertain closing any acquisitions until we have more clarity around what's happening from a tariff standpoint. We believe that there's going to be a very rich field out there of acquisition opportunities. Once this all is done, there are people competitors who are really suffering out there who were 100% reliant on China or vendors who were buying suppliers who are buying Chinese products and selling it to them. So we believe we're going to be better positioned than anybody else to take advantage of that. On the call center side, we're still looking for geography, a lower cost, and we're doing a lot of exploration there, whether we do that through acquisition or wind up doing it on its own. The jury is still out. We're still exploring both those possibilities. And right now, though, from an acquisition standpoint, there would have to be a really compelling reason to do one. And I would tell you, it would have to be immediately accretive and have to be bought at the right price.

Got it. All right. Well, thank you very much, guys, and wish you the best for the balance of the year.

Thank you. I want to thank our loyal customers and our dedicated employees for their tremendous efforts. As shareholders, you can rest assured we're making the most of current macro conditions while keeping our eye on the prize, which is a compelling long-term outlook for each of our three attractive businesses. We'll keep you updated as we move through the year, and please don't hesitate to reach out with any additional questions. Thanks again for your interest in SGC, and enjoy the evening.

The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.